Fig. 8: Prognostic correlation analysis of IFNG in different cancer patients.
From: Interferon signaling and ferroptosis in tumor immunology and therapy
A–J Analysis of the overall survival time in different cancer patients (n = 10327) based on the expression level of IFNG; K Validation of the correlation between the expression level of IFNG and prognosis in THYM patients (n = 115) using the GEPIA website. LGG brain lower grade glioma, OV ovarian serous cystadenocarcinoma, SARC sarcoma, SKCM skin cutaneous melanoma, THYM thymoma, UVM uveal melanoma.
